Characterization of Nanomaterials for Toxicological Evaluation

Nanotoxicity: From In Vivo and In Vitro Models to Health Risks

Volumn , Issue , 2009, Pages 1-27

  Powers, Kevin W ^a   Palazuelos, Maria ^a   Brown, Scott C ^a   Roberts, Stephen M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Nanoparticle Information Library (NIL); Nanostructured materials (NSMs) proper characterization in toxicological evaluation; NSM sampling characterization and powder technology; NSMs and scanning electronmicroscopy (SEM), TEM and AFM; NSMs dispersed in liquid measurement and centrifugal sedimentation; Particle shape and toxicity; Particle size and toxicity importance; Quantifying NSM size, shape and agglomerate structure; Sampling variability and bulk heterogeneity increase; Understanding NSMs properties and toxicity mechanism determination

Indexed keywords

EID: 84860132547     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470747803.ch1     Document Type: Chapter

References (57)

1. Adamson NJ, Reynolds EC (1997) Rules relating electrophoretic mobility, charge and molecular size of peptides and proteins. J Chromatogr B 699, 133-147.
2. Aitken R, Creely K, Tran C (2004) Nanoparticles: An Occupational Hygiene Review. Research Report 274, Health and Safety Executive (ed.), Institute of Occupational Medicine. HSE Books: London.
3. Allen T (2004) Particle Size Measurement, Vol I: Powders Sampling and Particle Size Measurement (5th edn). Chapman and Hall: London.
4. Bailey MR, Ansoborlo E, Guilmette RA, Paquet F (2003) Practical application of the ICRP Human Respiratory Tract Model. Radiat Prot Dosimetry 105, 71-76 (2003).
5. Balbus JM, Maynard AD, Colvin VL, Castranova V, Daston GP, Denison RA, Dreher KL, Goering PL, Goldberg AM, Kulinowski KM, Monteiro-Riviere NA, Oberdorster G, Omenn GS, Pinkerton KE, Ramos KS, Rest KM, Sass JB, Silbergeld EK, Wong BA (2007) Meeting report: Hazard assessment for nanoparticles-Report from an interdisciplinary workshop. Environ Health Persp 115, 1654-1659.
6. Baron PA, Willeke K (2001) Aerosol Measurement Principles, Techniques, and Applications. John Wiley & Sons, Ltd: Chichester.
7. Berne BJ, Pecora R (2000) Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics. Dover Publications: Minoela, NY.
8. Berry CC, Dalby MJ, McCloy D, Affrossman S (2005) The fibroblast response to tubes exhibiting internal nanotopography. Biomaterials 26, 4985-4992.
9. Bootz A, Vogel V, Schubert D, Kreuter J (2004) Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm 57, 369-375.
10. Bootz A, Russ T, Gores F, KarasM, Kreuter J (2005) Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography. Eur J Pharm Biopharm 60, 391-399.
11. Borchert H, Shevehenko EV, Robert A, Mekis I, Kornowski A, Grubel G, Weller H (2005) Determination of nanocrystal sizes: A comparison of TEM, SAXS, and XRD studies of highly monodisperse COPt3 particles. Langmuir 21, 1931-1936.
12. Bucher J, Masten S, Moudgil B, Powers K, Roberts S, Walker N (2005) Developing Experimental Approaches for the Evaluation of Toxicological Interactions of Nanoscale Materials. Workshop Report, University of Florida.
13. Burtscher H (2005) Physical characterization of particulate emissions from diesel engines: a review. J Aerosol Sci 36, 896-932.
14. Driscoll KE, Howard BW, Carter JM, Asquith T, Johnston C, Detilleux P, Kunkel SL, Isfort RJ (1996) Alpha-quartz-induced chemokine expression by rat lung epithelial cells-effects of in vivo and in vitro particle exposure. Am J Pathol 149, 1627-1637.
15. Dukhin AS, Shilov VN, Ohshima H, Goetz PJ (1999) Electroacoustic phenomena in concentrated dispersions: New theory and CVI experiment. Langmuir 15, 6692-6706.
16. Fritz H, Maier M, Bayer E (1997) Cationic polystyrene nanoparticles: preparation and characterization of a model drug carrier system for antisense oligonucleotides. J Colloid Interface Sci 195, 272-288.
17. Glatter O, Kratky O (1982) Small Angle X-Ray Scattering. Academic Press: London.
18. Gutwein LG,Webster TJ (2002) Osteoblast and chrondrocyte proliferation in the presence of alumina and titania nanoparticles. J Nanopart Res 4, 231-238.
19. Hart GA, Hesterberg TW (1998) In vitro toxicity of respirable-size particles of diatomaceous earth and crystalline silica compared with asbestos and titanium dioxide. J Occup Environ Med 40, 29-42.
20. Hentschel ML, Page NW (2003) Selection of descriptors for particle shape characterization. Part and Part Syst Char 20, 25-38.
21. Heyder J (2004) Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc 1, 315-320.
22. HindsWC(1999) Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles (2nd edn). Wiley-Interscience: Chichester.
23. Holdich R (2002) Fundamentals of Particle Technology. Midland Information Technology & Publishing: Nottingham.
24. ISO-9276-6 (2008) Representation of results of particle size analysis-Part 6: Descriptive and quantitative representation of particle shape and morphology. International Organization for Standardization: Geneva.
25. ISO-15901-2 (2006) Pore size distribution and porosity of solid materials bymercury porosimetry and gas adsorption-Part 2: Analysis of mesopores and macropores by gas adsorption. International Organization for Standardization: Geneva.
26. Jarvis P, Jefferson B, Gregory J, Parsons SA (2005) A review of floc strength and breakage. Water Res 39, 3121-3137.
27. Jillavenkatesa A, Dapkunas S, Lum LSH, NIST (2001) Particle Size Characterization. US Dept. of Commerce, Technology Administration, National Institute of Standards and Technology: Gaithersburg, MD.
28. Jillavenkatesa A, Kelly JF (2002) Nanopowder characterization: challenges and future directions. J Nanopart Res 4, 463-468.
29. Kim CS, Okuyama K, de la Mora JF (2003) Performance evaluation of an improved particle sice magnifier (PSM) for single nanoparticle detection. Aerosol Sci and Tech 37, 791-803.
30. Knapp JZ, Barber TA, Lieberman A (1996) Liquid and Surface-Borne Particle Measurement Handbook. Marcel Dekker: New York.
31. Kostarelos K (2008) The long and short of carbon nanotube toxicity. Nat Biotechnol 26, 774-776.
32. Leggett RW, Eckerman KF (2003) Dosimetric Significance of the ICRP's Updated Guidance and Models, 1989-2003, and Implications for U.S. Federal Guidance. ORNL/TM-2003/207.
33. Lucarelli M, Gatti AM, Savarino G, Quattroni P, Martinelli L, Monari E, Boraschi D (2004) Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur Cytokine Netw 15, 339-346.
34. Masuda H, Inoya K (1971) Theoretical study of the scatter of experimental data due to particle-size distribution. J of Chem Eng of Japan 4, 60-66.
35. Masuda H, Gotoh K (1999) Study on the sample size required for the estimation of mean particle diameter. Adv Powder Technol 10, 159-173.
36. Nemmar A, Vanbilloen H, Hoylaerts MF, Hoet PH, Verbruggen A, Nemery B (2001) Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med 164, 1665-1668.
37. Neumann AW, Spelt JK (1996) Applied Surface Thermodynamics. Marcel Dekker: New York.
38. National Research Council (1989) Biological Markers in Pulmonary Toxicology.NationalAcademies Press: Washington, DC.
39. Oberdorster G (2001) Pulmonary effects of inhaled ultrafine particles. Int Arch Occ Env Hea 74, 1-8.
40. Oberdorster G, Ferin J, Lehnert BE (1994) Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102 (Suppl. 5), 173-179.
41. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H (2005) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Particle and Fibre Toxicology 2, 8.
42. Organisation for Economic Co-operation and Development (OECD) (2008) List of Manufactured Nanomaterials and List of Endpoints for Phase One of the OECD Testing Programm. Series on the Safety of Manufactured Nanomaterials, Number 6. OECD: Paris
43. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3, 423-428.
44. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM (2006) Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90, 296-303.
45. Ratner BD (1996) The engineering of biomaterials exhibiting recognition and specificity. J Mol Recognit 9, 617-625.
46. Renwick LC, Donaldson K, Clouter A (2001) Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 172, 119-127.
47. Roco MC (2001) International strategy for nanotechnology research and development. J Nanopart Res 3, 353-360.
48. Royal Society and Royal Academy of Engineering (2004) Nanoscience and Nanotechnologies: Opportunities and Uncertainties. RS Policy Document 19/04. Royal Society: London.
49. Ruzer LS, Harley NH (2005) Aerosols Handbook: Measurement, Dosimetry, and Health Effects. CRC Press: London.
50. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (2005) The appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. Health & Consumer Protection Directorate-General, European Commission: Brussels.
51. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (2007) The appropriateness of the risk assessment methodology in accordance with the Technical Guidance Documents for new and existing substances for assessing the risks of nanomaterials. Health & Consumer Protection Directorate-General, European Commission: Brussels.
52. Sears GW (1956) Determination of specific surface area of colloidal silica by titration with sodium hydroxide. Anal Chem 28, 1981-1983.
53. Sjostrom B, Kaplun A, Talmon Y, Cabane B (1995) Structures of nanoparticles prepared from oil-in-water emulsions. Pharm Res 12, 39-48.
54. Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, Kitajima S, Kanno J (2008) Induction of mesothelioma in p53+/-mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 33, 105-116.
55. Thomas K, Sayre P (2005) Research strategies for safety evaluation of nanomaterials, part I: Evaluating the human health implications of exposure to nanoscale materials. Toxicol Sci 87, 316-321.
56. US Environmental Protection Agency (EPA), Office of Pollution Prevention and Toxics (2009) Nanoscale Materials Stewardship Program. Interim Report.
57. Wasdo SC, Barber DS, Denslow ND, Powers KW, PalazuelosM, Stevens SM,Moudgil BM, Roberts SM (2008) Differential binding of serum proteins to nanoparticles. Int J Nanotechnol 5, 92-115.